| Website | presidiopharma.com |
| Category | BioTech |
| Phone | 415-655-7560 |
| Employees | |
| Description | biotech trials |
| Total | $53M |
| Series B, 8/07 Panorama Capital Baker Brothers Investments Bay City Capital Ventures West Nexus Medical Partners | $26M |
| Unattributed, 7/09 New Leaf Venture Partners | $27M |
Presidio Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the discovery, in-licensing, development and commercialization of novel therapeutics for viral infections, including HCV and HIV. Presidio has raised over $27 million in financing from Panorama Capital, Baker Brothers Investments, Bay City Capital, Ventures West, Nexus Medical Partners, and Sagamore Bioventures LLC.